Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03492125 |
| Title | A Study Of The Selective PKC-beta Inhibitor MS- 553 |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | MingSight Pharmaceuticals, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University Of Michigan Comprehensive Cancer Center | Ann Arbor | Michigan | 48109 | United States | Details | |
| Columbia University, Herbert Irving Comprehensive Cancer Center | New York | New York | 10032 | United States | Details | |
| The Ohio State University, James Comprehensive Cancer Center | Columbus | Ohio | 43210 | United States | Details | |
| MD Anderson Cancer Center, Department of Leukemia | Houston | Texas | 77030 | United States | Details | |
| Huntsman Cancer Institute | Salt Lake City | Utah | 84112 | United States | Details |